Yawara Eguchi, Yasuchika Aoki, Masaomi Yamashita, Kazuki Fujimoto, Takashi Sato, Koki Abe, Masashi Sato, Hajime Yamanaka, Toru Toyoguchi, Keisuke Shimizu, Sumihisa Orita, Kazuhide Inage, Yasuhiro Shiga, Seiji Ohtori
PURPOSE: We compared the clinical effects of Neurotropin, limaprost alfadex, and a combination of both drugs for lumbar spinal stenosis (LSS) with low back pain (LBP). METHODS: We conducted a multicenter, randomized, active-controlled, open-label trial from March 2021 to May 2022. Participants were patients diagnosed with LSS by MRI and were randomly assigned to three groups: Neurotropin/limaprost combination (NL group), Neurotropin (N group), and limaprost group (L group)...
January 16, 2023: Pain and Therapy